quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:54:11·1d
ANALYSTRating
Valneva SE logo

Valneva SE downgraded by Goldman with a new price target

VALN· Valneva SE
Health Care
Original source

Companies

  • VALN
    Valneva SE
    Health Care

Recent analyst ratings

  • Apr 22UpdateGoldman$4.90
  • Aug 19UpdateH.C. Wainwright$18.00
  • Aug 3UpdateH.C. Wainwright$34.00

Related

  • SEC28d
    SEC Form 6-K filed by Valneva SE
  • PR28d
    Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
  • SEC31d
    SEC Form 6-K filed by Valneva SE
  • PR31d
    Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
  • SEC36d
    SEC Form 6-K filed by Valneva SE
  • PR36d
    Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
  • PR37d
    Valneva Reports Full Year 2025 Audited Consolidated Financial Results
  • SEC37d
    SEC Form 20-F filed by Valneva SE
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022